A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy

Research output: Other contributionOther

Original languageAmerican English
StatePublished - 2011

Disciplines

  • Epidemiology
  • Public Health

Cite this